Fate Therapeutics (FATE) Return on Sales [ROS] (2012 - 2026)
Fate Therapeutics' Return on Sales [ROS] was -1495.39% in Q2 2026, up 443.15 percentage points from -1938.54% a year earlier and up 1045.03 percentage points from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Return on Sales [ROS] (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Fate Therapeutics' Return on Sales [ROS] was -2058.08% through Jun 30, 2026, up 213.15 percentage points year-over-year; for FY2025, it was -2222.45%, down 679.82 percentage points from FY2024.
- Return on Sales [ROS] shows a five-year change of -1814.98 percentage points (FY2020 to FY2025).
- In earlier years, Return on Sales [ROS] was -1542.63% in FY2024 (-1242.77 pp), -299.86% in FY2023 (+20.37 pp), -320.23% in FY2022 (+68.32 pp) and -388.56% in FY2021 (+18.91 pp).
- The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] since Q2 2024.
- Compared with a year earlier, Return on Sales [ROS] was higher in four of the last eight quarters, with an average year-over-year change of +32.21 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q2 2024 (a gain of 6040.06 percentage points); the worst was Q2 2023 (a drop of 6257.74 percentage points).
- Per Business Quant data, FATE's Return on Sales [ROS] in the three quarters before Q2 2026 was -2540.42% (Q1 2026), -2536.23% (Q4 2025) and -1995.12% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Fate Therapeutics | 270.73 Mn | 270.73 Mn | - | -1,495.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,495.39% |
| Mar 31, 2026 | -2,540.42% |
| Dec 31, 2025 | -2,536.23% |
| Sep 30, 2025 | -1,995.12% |
| Jun 30, 2025 | -1,938.54% |
| Mar 31, 2025 | -2,534.07% |
| Dec 31, 2024 | -3,319.78% |
| Sep 30, 2024 | -1,703.87% |
| Jun 30, 2024 | -665.73% |
| Mar 31, 2024 | -2,652.88% |
| Dec 31, 2023 | -2,868.44% |
| Sep 30, 2023 | -2,637.81% |
| Jun 30, 2023 | -6,705.79% |
| Mar 31, 2023 | -48.48% |
| Dec 31, 2022 | -145.23% |
| Sep 30, 2022 | -576.67% |
| Jun 30, 2022 | -448.05% |
| Mar 31, 2022 | -404.40% |
| Dec 31, 2021 | -406.48% |
| Sep 30, 2021 | -383.99% |
API Access
Fate Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();